APGE CIK: 1974640

Apogee Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotechnology
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY22 – FY25

Assets

(positive)
Change from FY22 to FY25
millions USD
FY22:
152
FY23:
398
FY24:
530
FY25:
741
(positive)
millions USD
FY22:
0
FY23:
3.00
FY24:
224
FY25:
196
Total assets
Change from FY22 to FY25
millions USD
FY22:
152
FY23:
401
FY24:
754
FY25:
937

Liabilities & Equity

(negative)
Change from FY22 to FY25
millions USD
FY22:
9.98
FY23:
20.6
FY24:
28.6
FY25:
27.9
(negative)
millions USD
FY22:
0
FY23:
0.93
FY24:
8.60
FY25:
5.35

All amounts in millions USD Data source:SEC EDGAR